SAMD11: A Unique Protein with Potential as A Drug Target and Biomarker

Target Name: SAMD11

NCBI ID: G148398

SAMD11

Other Name(s): sterile alpha motif domain containing 11 splice variant ASV11 | sterile alpha motif domain containing 11 splice variant ASV41 | sterile alpha motif domain containing 11 splice variant ASV17 | sterile alpha motif domain containing 11 splice variant ASV38 | sterile alpha motif domain containing 11 splice variant ASV2 | sterile alpha motif domain containing 11 splice variant ASV20 | SAMD11 variant 3 | sterile alpha motif domain containing 11 splice variant ASV40 | sterile alpha motif domain containing 11 splice variant ASV1 | sterile alpha motif domain containing 11 splice variant ASV23 | sterile alpha motif domain containing 11 splice variant ASV35 | sterile alpha motif domain containing 11 splice variant ASV42 | sterile alpha motif domain containing 11 splice variant ASV39 | sterile alpha motif domain containing 11 splice variant ASV16 | sterile alpha motif domain containing 11 splice variant ASV19 | sterile alpha motif domain containing 11 splice variant ASV21 | Sterile alpha motif domain-containing protein 11 | SAM11_HUMAN | sterile alpha motif domain containing 11 splice variant ASV6 | sterile alpha motif domain containing 11 splice variant ASV31 | sterile alpha motif domain containing 11 splice variant ASV43 | sterile alpha motif domain containing 11 splice variant ASV4 | Sterile alpha motif domain containing 11, transcript variant 3 | sterile alpha motif domain containing 11 splice variant ASV26 | sterile alpha motif domain containing 11 splice variant ASV32 | SAM domain-containing protein 11 | sterile alpha motif domain containing 11 splice variant ASV34 | sterile alpha motif domain containing 11 splice variant ASV9 | sterile alpha motif domain containing 11 splice variant ASV18 | sterile alpha motif domain containing 11 splice variant ASV44 | sterile alpha motif domain containing 11 splice variant ASV27 | sterile alpha motif domain containing 11 splice variant ASV36 | sterile alpha motif domain containing 11 splice variant ASV28 | sterile alpha motif domain containing 11 splice variant ASV14 | sterile alpha motif domain containing 11 splice variant ASV7 | Sterile alpha motif domain-containing protein 11 isoform 3 | sterile alpha motif domain containing 11 splice variant ASV45 | sterile alpha motif domain-containing protein 11 | sterile alpha motif domain containing 11 splice variant ASV29 | sterile alpha motif domain containing 11 splice variant ASV5 | sterile alpha motif domain containing 11 splice variant ASV3 | sterile alpha motif domain containing 11 splice variant ASV37 | sterile alpha motif domain containing 11 splice variant ASV33 | sterile alpha motif domain containing 11 splice variant ASV10 | sterile alpha motif domain containing 11 splice variant ASV30 | sterile alpha motif domain containing 11 splice variant ASV12 | MRS | sterile alpha motif domain containing 11 splice variant ASV24 | sterile alpha motif domain containing 11 splice variant ASV8 | sterile alpha motif domain containing 11 splice variant ASV13 | sterile alpha motif domain containing 11 splice variant ASV25 | sterile alpha motif domain containing 11 splice variant ASV15 | sterile alpha motif domain containing 11 splice variant ASV22 | sterile alpha motif domain containing 11

SAMD11: A Unique Protein with Potential as A Drug Target and Biomarker

SAMD11, also known as sterile alpha motif domain containing 11, is a protein that is found in various cell types throughout the body. It is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression. SAMD11 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The SAMD11 protein is composed of 11 splice variants, which are alternative splicing variants of the same gene. These splice variants give the protein a unique structure and can lead to differences in its function. The sterile alpha motif domain of SAMD11 is a unique feature that is found in the gene. It is a region of the protein that contains a specific sequence that is responsible for its unique structure and function.

SAMD11 has been shown to play a role in the regulation of gene expression in various cell types. For example, studies have shown that SAMD11 can regulate the expression of genes involved in cell growth, differentiation, and apoptosis. Additionally, SAMD11 has been shown to play a role in the regulation of gene expression in the immune system, where it has been shown to regulate the production of immune cells and the response to infections.

SAMD11 has also been identified as a potential drug target for various diseases. For example, studies have shown that SAMD11 is involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Additionally, SAMD11 has been shown to be involved in the development and progression of cancer, including breast cancer and colorectal cancer.

One of the key advantages of SAMD11 as a drug target is its unique structure and function. The sterile alpha motif domain of SAMD11 is a specific sequence that is responsible for its unique structure and function. This domain is known for its ability to interact with other proteins and molecules, which can lead to its unique structure and function.

In addition, the SAMD11 protein is a non-coding RNA molecule, which means that it does not have a defined function. This allows researchers to study its structure and function in more detail than with proteins that have a defined function. This is important for the development of new drugs that can specifically target the SAMD11 protein.

Another advantage of SAMD11 is its potential to be used as a biomarker. The SAMD11 protein is a protein that is expressed in various cell types throughout the body, which makes it a potential biomarker for a variety of diseases. For example, studies have shown that SAMD11 is expressed in breast tissue and has been used as a biomarker for breast cancer. Additionally, SAMD11 has been shown to be expressed in the brains of individuals with Alzheimer's disease, which makes it a potential biomarker for this disease.

In conclusion, SAMD11 is a protein that has unique structure and function, making it a potential drug target. Its potential as a drug target is due to its ability to interact with other proteins and molecules, as well as its non-coding RNA molecule status. Its potential as a biomarker is due to its expression in various cell types throughout the body, which makes it a potential indicator of disease. Further research is needed to fully understand the role of SAMD11 in disease and to develop new drugs that can specifically target it.

Protein Name: Sterile Alpha Motif Domain Containing 11

Functions: May play a role in photoreceptor development

The "SAMD11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SAMD11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets